JP2022533672A - 肝障害を処置するための方法および組成物 - Google Patents

肝障害を処置するための方法および組成物 Download PDF

Info

Publication number
JP2022533672A
JP2022533672A JP2021568854A JP2021568854A JP2022533672A JP 2022533672 A JP2022533672 A JP 2022533672A JP 2021568854 A JP2021568854 A JP 2021568854A JP 2021568854 A JP2021568854 A JP 2021568854A JP 2022533672 A JP2022533672 A JP 2022533672A
Authority
JP
Japan
Prior art keywords
subject
composition
microbial
liver
ast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021568854A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020236979A5 (https=
JP2022533672A5 (https=
Inventor
オービル コルターマン、
ファニー ペロドー、
ジェームズ ブラード、
ジョン エイド、
コリーン カットクリフ、
Original Assignee
ペンデュラム セラピューティクス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ペンデュラム セラピューティクス， インコーポレイテッド filed Critical ペンデュラム セラピューティクス， インコーポレイテッド
Publication of JP2022533672A publication Critical patent/JP2022533672A/ja
Publication of JPWO2020236979A5 publication Critical patent/JPWO2020236979A5/ja
Publication of JP2022533672A5 publication Critical patent/JP2022533672A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP2021568854A 2019-05-21 2020-05-20 肝障害を処置するための方法および組成物 Pending JP2022533672A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962850773P 2019-05-21 2019-05-21
US62/850,773 2019-05-21
PCT/US2020/033870 WO2020236979A1 (en) 2019-05-21 2020-05-20 Methods and compositions for treating liver disorders

Publications (3)

Publication Number Publication Date
JP2022533672A true JP2022533672A (ja) 2022-07-25
JPWO2020236979A5 JPWO2020236979A5 (https=) 2023-05-25
JP2022533672A5 JP2022533672A5 (https=) 2023-05-25

Family

ID=73458208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021568854A Pending JP2022533672A (ja) 2019-05-21 2020-05-20 肝障害を処置するための方法および組成物

Country Status (10)

Country Link
US (1) US20220211780A1 (https=)
EP (1) EP3973047A4 (https=)
JP (1) JP2022533672A (https=)
KR (1) KR20220011683A (https=)
CN (1) CN113993529A (https=)
AU (1) AU2020278703A1 (https=)
CA (1) CA3140096A1 (https=)
SG (1) SG11202112515RA (https=)
WO (1) WO2020236979A1 (https=)
ZA (1) ZA202110111B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
SG11202112515RA (en) * 2019-05-21 2021-12-30 Pendulum Therapeutics Inc Methods and compositions for treating liver disorders
NL2030011B1 (en) * 2021-12-03 2023-06-20 Caelus Pharmaceuticals B V Prevention or treatment of hepatic steatosis
EP4467148A4 (en) * 2022-01-20 2025-04-23 Korea Institute of Science and Technology Composition for prevention, amelioration or treatment of non-alcoholic fatty liver disease, comprising extracellular vesicles derived from roseburia spp. or bifidobacterium spp
CN117599092B (zh) * 2024-01-23 2024-04-26 南方医科大学南方医院 生孢梭菌在制备预防和/或治疗肝脏疾病的药物中的应用
CN118526527A (zh) * 2024-03-19 2024-08-23 华中科技大学同济医学院附属协和医院 益生菌混合液在制备预防或治疗apap诱导肝损伤药物中的应用
KR102679094B1 (ko) * 2024-04-24 2024-06-27 충남대학교 산학협력단 항비만 효능을 지닌 한국인 마이크로바이옴 유래 클로스트리디움 부티리쿰 균주 및 이의 용도
CN119639633A (zh) * 2025-02-18 2025-03-18 杭州师范大学附属医院(杭州市第二人民医院) 一种治疗非酒精性脂肪肝的酵母菌益生菌复合物及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019046646A1 (en) * 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201903823QA (en) * 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
EP3402475B1 (en) * 2016-01-11 2021-10-20 Egetis Therapeutics AB Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions
AU2017370681A1 (en) * 2016-12-06 2019-06-27 Pendulum Therapeutics, Inc. Methods and compositions relating to isolated and purified microbes
AU2018341734B2 (en) * 2017-09-28 2022-02-03 Kobiolabs, Inc. Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community
CA3113684A1 (en) * 2018-09-24 2020-04-02 Pendulum Therapeutics, Inc. Microbial compositions and methods of use
SG11202112515RA (en) * 2019-05-21 2021-12-30 Pendulum Therapeutics Inc Methods and compositions for treating liver disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019046646A1 (en) * 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HITOSHI ENDO ET AL.: ""Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Ins", PLOS ONE, vol. 8, no. 5, JPN6024014418, 16 May 2013 (2013-05-16), pages 63388, ISSN: 0005462249 *

Also Published As

Publication number Publication date
CA3140096A1 (en) 2020-11-26
EP3973047A1 (en) 2022-03-30
EP3973047A4 (en) 2023-01-11
US20220211780A1 (en) 2022-07-07
CN113993529A (zh) 2022-01-28
ZA202110111B (en) 2024-04-24
KR20220011683A (ko) 2022-01-28
SG11202112515RA (en) 2021-12-30
WO2020236979A1 (en) 2020-11-26
AU2020278703A1 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
JP2022533672A (ja) 肝障害を処置するための方法および組成物
EP2481299B1 (en) Bifidobacterium bifidum strains for application in gastrointestinal diseases
US20210213078A1 (en) Microbial compositions and methods of use
US20170216328A1 (en) Methods and compositions for microbiome alteration
KR20110124780A (ko) 프리바이오틱 제제 및 사용 방법
WO2025246510A1 (zh) 一株长双歧杆菌长亚种及其在预防、缓解、调节或治疗脂代谢相关疾病中的应用
US12343360B2 (en) Methods and compositions for microbial engraftment
TWI671017B (zh) 組合包在製備用於改善和治療人類小胖威利綜合症的藥品中的應用
CN109419814B (zh) 戈氏副拟杆菌用于抑制脂肪肝疾病的用途
US20240277781A1 (en) Compositions Comprising Microbes and Methods of Use and Making Thereof
US11554131B2 (en) Mixture of HMOs for treating autoimmune diseases
CN106974262A (zh) 肠道益生杆菌在治疗和预防肥胖及其相关疾病中的应用
CN116836880B (zh) 一种普氏梭杆菌及其应用
CN106974940B (zh) 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
CN106974939B (zh) 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
Jordan Nelson Influence of Gut Microbiota–Derived Short-Chain Fatty Acids on Insulin Sensitivity in Type 2 Diabetes Mellitus
JP2026507015A (ja) プレバイオティクス組成物
JP2026503447A (ja) 心血管代謝状態又は神経変性状態における尿毒症毒素を低下させるためのマイクロバイオーム材料の組み合わせ
TW202435902A (zh) 改善免疫力和治療特應性皮炎的合生元組合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230517

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230517

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240417

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240423

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240723

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20241119